These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 19025303)

  • 1. [Effect of Helicobacter pylori eradication on patients with functional dyspepsia].
    de Artaza Varasa T; Valle Muñoz J; Pérez-Grueso MJ; García Vela A; Martín Escobedo R; Rodríguez Merlo R; Cuena Boy R; Carrobles Jiménez JM
    Rev Esp Enferm Dig; 2008 Sep; 100(9):532-9. PubMed ID: 19025303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
    Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
    Kyzekova J; Mour J
    Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
    Talley NJ; Vakil N; Ballard ED; Fennerty MB
    N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia.
    Schütze K; Hentschel E; Hirschl AM
    Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):41-6. PubMed ID: 8900907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects.
    Lee VW; Chau TS; Chan AK; Lee KK; Waye MM; Ling TK; Chan FK
    J Clin Pharm Ther; 2010 Jun; 35(3):343-50. PubMed ID: 20831535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura.
    Matsukawa Y; Kato K; Hatta Y; Iwamoto M; Mizuno S; Kurihara R; Arakawa Y; Kurosaka H; Hayashi I; Sawada S
    Platelets; 2007 Feb; 18(1):52-5. PubMed ID: 17365854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
    Mazzoleni LE; Sander GB; Ott EA; Barros SG; Francesconi CF; Polanczyk CA; Wortmann AC; Theil AL; Fritscher LG; Rivero LF; Cartell A; Edelweiss MI; Uchôa DM; Prolla JC
    Dig Dis Sci; 2006 Jan; 51(1):89-98. PubMed ID: 16416218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
    Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
    Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
    Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
    N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia.
    Bruley Des Varannes S; Fléjou JF; Colin R; Zaïm M; Meunier A; Bidaut-Mazel C
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1177-85. PubMed ID: 11472320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
    Lamouliatte H; Samoyeau R; De Mascarel A; Megraud F
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1523-30. PubMed ID: 10571611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
    Suzuki H; Masaoka T; Sakai G; Ishii H; Hibi T
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1652-60. PubMed ID: 16246181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
    Miki I; Aoyama N; Sakai T; Shirasaka D; Wambura CM; Maekawa S; Kuroda K; Tamura T; Kita T; Sakaeda T; Okumura K; Kasuga M
    Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):27-33. PubMed ID: 12544691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
    Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
    BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.